Evaluation of apoptosis induction in HepG۲ cell line by inhibition of miR-۴۲۷۰
محل انتشار: کنفرانس بین المللی ژنتیک و ژنومیکس انسانی
سال انتشار: 1400
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 91
نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
این مقاله در بخشهای موضوعی زیر دسته بندی شده است:
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
CHGGE01_216
تاریخ نمایه سازی: 13 مهر 1401
چکیده مقاله:
Backgrounds: Hepatocellular carcinoma (HCC) is the most common type of liver cancer and avery common disease worldwide. Therefore, the discovery of new treatments in HCC isessential. MicroRNAs are small non-coding RNAs that play a role in post-transcriptional genesuppression and play a key role in regulating the cell cycle, including apoptosis. Apoptosis orprogrammed cell death has been shown to be most effective in inhibiting cancer growth. One ofthe distinctive biochemical features of apoptosis is DNA degradation by caspase-activatedDNase which makes DNA fragments ۱۸۰-۲۰۰ bp in length and are known as DNA ladders.Materials and Methods: For this purpose, HepG۲ cells were cultured in RPMI ۱۶۴۰ Mediumwith ۱۰% FBS and antibiotics at ۳۷°C. Then MTT assay was performed to determine the cellviability and the appropriate concentrations of the specific hsa-miR-۴۲۷۰ inhibitor for DNAladdering assay. Finally, DNA was extracted from hsa-miR-۴۲۷۰ inhibitor at concentrations ۲۰,۴۰ and ۸۰ nM and were electrophoresis onto the agarose gel to investigate DNA laddering andapoptosis.Results: The results showed treatment of HepG۲ cells with the hsa-miR-۴۲۷۰ inhibitor at ۴۰ and۸۰ nM concentrations induced laddering pattern of DNA and apoptosis compared to ۲۰ nM ofhsa-miR-۴۲۷۰ inhibitor and untreated HepG۲ cells.Conclusion: Inhibition of miR-۴۲۷۰ (known as an oncomiR) induced apoptosis in the HepG۲cell line and inhibited the growth of HepG۲ cells.
کلیدواژه ها:
نویسندگان
Hanieh Gholami
Shahid Bahonar University of Kerman, Faculty of Science, Department of Biology
Hosseinali Sassan
Shahid Bahonar University of Kerman, Faculty of Science, Department of Biology
Hassan Akrami
Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Nasrollah Erfani
Department of Immunology School of Medicine Shiraz university of Medical sciences, Shiraz, Iran- Cancer Immunology & Immunotherapy Group, Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences, Shiraz, Iran